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Abstract
Novel geometrical chemical descriptors have been derived based on the computational geometry of
protein-ligand interfaces and Pauling atomic electronegativities (EN). Delaunay tessellation has been
applied to a diverse set of 517 X-ray characterized protein-ligand complexes yielding a unique
collection of interfacial nearest neighbor atomic quadruplets for each complex. Each quadruplet
composition was characterized by a single descriptor calculated as the sum of the EN values for the
four participating atom types. We termed these simple descriptors generated from atomic EN values
and derived with the Delaunay Tessellation the ENTess descriptors and used them in the variable
selection k-Nearest Neighbor quantitative structure-binding affinity relationship (QSBR) studies of
264 diverse protein-ligand complexes with known binding constants. 24 complexes with chemically
dissimilar ligands were set aside as an independent validation set, and the remaining dataset of 240
complexes was divided into multiple training and test sets. The best models were characterized by
the leave-one-out cross-validated correlation coefficient q2 as high as 0.66 for the training set and
the correlation coefficient R2 as high as 0.83 for the test set. High predictive power of these models
was confirmed independently by applying them to the validation set of 24 complexes yielding R2 as
high as 0.85. We conclude that QSBR models built with the ENTess descriptors can be instrumental
for predicting the binding affinity of receptor-ligand complexes.
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INTRODUCTION
The prediction of the protein-ligand binding affinity is a critical component of computational
drug discovery. Rapid growth of the Protein Data Bank1 provides opportunities to enhance
current protocols for molecular docking and scoring, which are at the core of structure-based
drug design2–5 and hit identification6–8. Accurate estimation of binding affinities, or at least
correct relative ranking of different ligands has proven to be a difficult task due to multiple
energetic and entropic factors that must be accounted for9,10. The limited accuracy of current
scoring functions is one of the problems hampering the broad application of docking and virtual
screening in lead optimization.
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Many scoring functions have been developed over the years. Force field scoring is based on
the classical molecular force field (such as AMBER11, CHARMM12, MMFF9413) to compute
non-bonded interaction terms between the receptor and ligand atoms. Additional empirical
terms taking into account the effects of solvation and entropy have also been considered14. The
second family of methods includes so-called empirical scoring functions such as LUDI15,
VALIDATE16, and ChemScore17. They are based on the concept that the receptor-ligand
interaction energy can be approximated by a multivariate regression of different parameters,
e.g., the number of hydrogen bonds, lipophilicity, ionic interactions, entropy penalties, etc.
Recently, a third family of methods, based on statistical scoring functions (e.g.,
DrugScore18, SMoG19,20, PMF21, BLEEP22, and distance dependent atom pair
descriptors23) has become popular. These methods employ the statistical analysis of known
receptor-ligand complexes to define the pairwise inter-atomic potential of protein-ligand
interaction. After the calibration on the training set of complexes, these scoring functions are
validated by predicting binding affinities for the complexes of the test sets.
Since the force field based scoring functions are too computationally demanding to allow for
efficient virtual screening of large databases24, the application of this method is usually limited
to small datasets. Of the three approaches outlined above, empirical scoring functions are the
most computationally efficient and therefore most widely used in current docking programs.
Knowledge-based scoring functions are based on the compositional analysis of protein-ligand
complexes. They derive their origin from protein fold recognition studies in the 70’s25. Today
the growing sources1,26–28 of structural information on protein-ligand complexes provide great
advantages for the continuing development and enhancement of statistical scoring functions.
Studies have shown that in many cases knowledge-based scoring functions surpass both force
field-based and empirical ones in predicting correct binding modes and affinities of the ligands.
At the same time, they are fast and accurate, and at least comparable to empirical scoring
functions in the efficiency of virtual screening of large databases and combinatorial lead
design2–4,8,18,20–22,29.
All methodologies discussed above rely on the availability of structural information about
protein-ligand complexes and are classified as structure-based drug design approaches. In
contrast, ligand based approaches rely only on the experimental structure-activity relationships
for ligands only. Quantitative structure-activity relationship (QSAR)30 methods are typically
used to find correlations between ligands’ binding affinities and their chemical descriptors.
Some 3D-QSAR methods such as comparative molecular field analysis (CoMFA) have been
developed to find correlation between binding affinities and energetic fields surrounding small
molecules such as steric, electrostatic, hydrophobic, etc.31–33 The “fields” are thought to
simulate the active site environment but they actually do not consider the receptor geometry
or the structural information of the active site (although CoMFA does provide an option to use
active site atoms as opposed to a “probe” atom to sample the interaction fields). Several so-
called receptor-dependent quantitative structure-activity relationship (RD-QSAR) methods
have been developed that rely on the receptor structure information to calculate independent
variables23,34. Holloway and co-workers35 have derived a highly significant 3D-QSAR model
for HIV-1 protease and its peptidomimetic inhibitors and used it to predict binding affinities
for newly designed ligands. Several other authors16,36,37 have developed new methodologies
by considering all of the enthalpic and entropic contributions as well as solvation effects of the
receptor-ligand interactions and treated them as independent variables in the RD-QSAR
development.
In this paper, we present a hybrid methodology to predict the binding affinities for a highly
diverse dataset of protein-ligand complexes using concepts from both structure-based and
ligand-based approaches. It is based on four-body statistical scoring function derived by
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combined application of the Delaunay tessellation of protein-ligand complexes and the
definition of chemical atom types using the fundamental chemical concept of atomic
electronegativity. As described in our previous publications,38–42 Delaunay tessellation
naturally partitions a tertiary structure of a protein or a protein-ligand complex into an aggregate
of space-filling, irregular tetrahedra, or simplices; the vertices of the simplices are quadruplets
of nearest neighbor residues or atoms, respectively (Figure 1). Thus Delaunay tessellation
reduces a complex three-dimensional structure to a collection of explicit, elementary atomic
quadruplet structural motifs. Four vertices (atoms) of a simplex form a particular quadruplet
composition and the chemical properties of the atom types can characterize the type of the
tetrahedron.
Atom types can be defined in a number of ways16,20–22,43. In general, atoms can be classified
into polar and non-polar carbon atoms, HBA (hydrogen bond acceptor) and HBD (hydrogen
bond donor), X (halogens), M (metals), cations, anions, and hydrophobic atoms. Herein we
present an unconventional way to define atom types using a scale of Pauling electronegativities
(EN). To the best of our knowledge, EN has never been used previously to define atom types
in a statistical scoring function. We apply atomic EN values to generate descriptors of all
quadruplet atomic composition observed frequently at the interface of ligand-receptor
complexes in a training set of 517 diverse X-ray characterized protein-ligand complexes: the
single descriptor for a specific composition is obtained as a sum of the EN values for composing
chemical atom types. Since these descriptors are based on the constructs from computational
geometry (Delaunay Tessellation) combined with the fundamental chemical property of
composing atom types such as Pauling EN, we term them geometrical chemical, or ENTess
descriptors. Herein, we report on the use of the ENTess descriptors as independent variables
in multivariate correlation analysis of the experimental dataset of 264 diverse protein-ligand
complexes with known binding constants. Following the protocols for developing validated
and predictive QSAR models established in the course of our previous studies44–47, we have
divided this datasets into the training, test, and independent validation sets. We report
statistically significant Quantitative Structure-Binding Affinity Relationships (QSBR) models
capable of predicting the binding affinities of ligands in the independent validation set with
the R2 of 0.85.
MATERIALS AND METHODS
1. Datasets
In order to develop the ENTess descriptors, we have used two datasets. The first dataset
included 517 protein-ligand complexes with high resolution (below 3.0Å) X-ray crystal
structures2,4,16,18,20–22,28,48–50. This dataset was used to generate the statistics of quadruplet
atom compositions resulting from Delaunay tessellation of protein-ligand interfaces as
discussed below. The second dataset was a subset of the first dataset. It included 264 protein-
ligand complexes with known binding affinities (pKi) ranging between 1.48 (1XLI) and 13.96
(7CPA) log units of molar concentration. The molecular weight of ligands ranged from tens
to more than one thousand Daltons. The data were collected from the recent publications2,4,
16,18,20–22,28,48–50. All of the structures in the datasets were prepared for the subsequent
analysis as follows: hydrogen atoms and water molecules were discarded; ligands were
extracted from the protein-ligand complex structures using SYBYL 6.9 and the ligand
structures were fixed according to Relibase which is an online ligand-receptor structure
database51. We followed the routine that was used by Gohlke and co-workers in their
DrugScore development18.
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2. Structural and Functional Diversity Analysis of the 264 Complexes
In order to evaluate the structural and functional diversity of this dataset, we have classified
the 264 complexes into different families based on their structural and functional annotations
using SWISS-PROT/PDB cross-referencing system52. According to this system, each PDB
entry is cross-referenced with the SWISS-PROT code, primary gene name (gene expressing
that protein) and its source or species of origin. If two proteins have the same primary gene
names, they will have very high sequence identity and their structures will be very similar. The
family associations of all training set complexes are shown in Table 1. In those cases where
no cross-referenced information was available (e.g., PDB entries 1dbb, 1mcf, etc.) the
complexes were placed in a group called “MISC”.
Based on the SWISS-PROT annotation, the 264 complexes were classified into 71 families
reflecting the high functional and structural diversity of this dataset. Some families had multiple
members and some had only one member. All of the protein structures within one family were
similar but the ligand structures were different; for different families both protein and ligand
structures were dissimilar. We have found that 14 PDB entries were not annotated in SWISS-
PROT/PDB cross-referencing system and they have been classified into “MISC” family.
3. Atom Type Definitions
In order to develop simple yet robust chemical geometrical descriptors, we sought some
fundamental atomic property that could be attributed to any chemical atom type of either
receptor or ligand and could be useful in describing interatomic interactions at the ligand-
receptor interface. We decided to use the Pauling electronegativity53 as a parameter to
characterize atom types. According to the chemical potential equalization principle as
described by Itskowitz and Berkowitz,54 electronegativity is the first order term in the energy
function of molecules:
(1)
where E is the energy of the molecule, μa is the electronegativity of atom a, Qa is the partial
charge on atom a, and η̃ is the hardness kernel. E0 is the collection of terms independent of
Qa; so electronegativity is the main factor determining the atom’s polarity and its ability to
form a hydrogen bond. For example, oxygen has high electronegativity and high ability to form
hydrogen bond and it is a polar atom type in most cases. Thus, electronegativity could be used
to describe the interactions between protein and ligand atoms. Hall et al. have introduced
electrotopological state (E-state) indices, which are indirectly related to electronegativity, and
successfully used them in QSAR studies of many datasets55. Recently Zefirov et al. used
electronegativity equalization scheme as a source of electronic descriptors to study some types
of chemical reactivity and obtained good models for thermodynamic and kinetic data such as
proton affinity and Taft's inductive sigma* constants.56
To collect the most representative statistics of possible ligand atom types, we relied on chemical
databases of biologically active organic compounds from the National Cancer Institute (NCI).
The first database contains 237,771 compounds57 and another includes 30,000 compounds
tested against 60 human cancer cell lines58. If an atom type occurred in more than 5,000 out
of the 237,771 compounds in the first NCI database, and in more than 1,500 compounds out
of 30,000 compounds in the NCI cancer database, we classified it as an independent atom type.
For example, O (EN=3.4), N (3.0), C (2.5) and S (2.4) were classified into independent atom
types according to their electronegativity values and their high occurrence in the databases.
Although halogens (F, Cl, Br and I) and P are also important atom types, since they occur
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independently less than 5,000 times in the NCI database and less than 1,500 times in the NCI
cancer database, they were classified into the same atom type X [P has very similar
electronegativity value to that of halogens except for F (between 2.0 ~ 2.4)]. Similarly, all
metal atoms have electronegativity values within 0.6 ~ 1.6, and along with some other rare
atom types, were classified into the same atom type M. Atom type definition for proteins is
relatively easier, since there are only four atom types, C, N, O and S that occur in natural amino
acids.
In order to distinguish ligand vs. protein atoms, we have classified the protein and ligand C,
N, O and S as different atom types. Hydrogen atoms were not considered since usually they
are not defined explicitly in the X-ray structures. Thus, we have defined four atom types for
receptor proteins and six atom types for the ligands. In total, there were 554 possible types of
interfacial atomic quadruplet compositions, and each of them gave rise to an independent
variable (a sum of EN values for composing atom types) for our QSBR studies. Atom type
definitions are summarized in Table 2.
4. Delaunay Tessellation of the Protein-Ligand Interfaces
We have developed programs for the protein-ligand complex tessellation based on the
nnsort method59. The protein-ligand interfaces were defined by tetrahedra formed by both
protein and ligand atoms. A distance cutoff value of 8Å was used to exclude Delaunay simplices
with long edges (exceeding the physically meaningful interaction distance) between vertices.
As shown in Figure 2, we have distinguished three classes of interfacial tetrahedra, i.e., RRRL,
RRLL and RLLL, where each R and L corresponds to a receptor and ligand atom, respectively.
For each class we further defined 554 types of quadruplet compositions based on our definition
of chemical atom types (cf. Table 2) without taking into account their order in the quadruplet.
For example, all quadruplets with atom types C_L, C_R, S_L and X_L, were assigned to the
same [X_L, S_L, C_L, C_R] composition type.
5. Dataset Division into Training, Test, and Independent Validation Sets
It is generally accepted that the internal validation of the QSAR models built for the training
set is sufficient to establish their predictive power60–69. However, our previous studies as well
as those conducted by other groups have demonstrated that there exists no correlation between
leave-one-out (LOO) cross-validated R2 (q2) for the training set and the correlation coefficient
R2 between the predicted and observed activities for the test set44,70. Our group has advocated
the importance of the external model validation which requires an independent set of
compounds.45,46,71 We have developed a rational approach to dividing the dataset into multiple
training and test sets for internal and external validations, respectively45,71,72. As described
below, we have extended our validation requirements to require not only test sets, but also a
second external test set (an independent validation set) for the additional validation.
The dataset of 264 complexes was divided into three subsets in the beginning of the
calculations. The first subset of 24 complexes for independent validation was selected
randomly. The remaining 240 complexes were divided into multiple chemically diverse
training and test sets with the algorithm based on Sphere Exclusion (SE) developed in our
group45. SE is a general procedure that is typically applied to databases of organic molecules
characterized by multiple descriptors of their chemical structure such that each compound is
represented as a point (or vector) in multidimensional descriptor space. The goal of the SE
method is to divide a dataset (i.e., a collection of points in multidimensional chemometric
space) into two subsets (training and test set) using diversity sampling procedure as follows.
SE starts with the calculation of the distance matrix D between representative points in the
descriptor space. Let Dmin and Dmax be the minimum and maximum elements of D,
respectively. N probe sphere radii are defined by the following formulas. Rmin=R1=Dmin,
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Rmax=RN=Dmax/4, Ri=R1+(i−1)*(RN−R1)/(N−1), where i=2,…,N−1. Each probe sphere
radius corresponds to one division into the training and test set.
In this paper, each receptor-ligand complex was characterized with multiple ENTess
descriptors as discussed in the first section under Results below. The entire dataset was then
treated as a collection of points (each corresponding to an individual receptor-ligand complex)
in the ENTess descriptor space. Thus, the SE algorithm used in this study consisted of the
following steps. (i) Select randomly a point in the ENTess descriptor space. (ii) Include it in
the training set. (iii) Construct a probe sphere around this point. (iv) Select points from this
sphere and include them alternatively into test and training sets. (v) Exclude all points within
this sphere from further consideration. (vi) If no more compounds left, stop. Otherwise let m
be the number of probe spheres constructed and n be the number of remaining points. Let dij
(i=1,…,m; j=1,…,n) be the distances between the remaining points and probe sphere centers.
Select a point corresponding to the lowest dij value and go to step (ii). The random division
was repeated three times and the results are summarized in Table 3. The training sets were used
to build models and the test sets were used for validation. The independent validation sets of
24 complexes were used for an additional external validation.
6. k-Nearest Neighbor (kNN) QSBR with Variable Selection
We have described this approach elsewhere73,74 and present here only its brief overview. kNN
QSAR is a stochastic variable selection procedure where the model optimization is driven by
simulated annealing, as is illustrated in Figure 3 The kNN procedure is aimed at the
development of the model with the highest leave-one-out (LOO) cross-validated correlation
coefficient R2 (q2) for the training set.
(2)
where N and ȳ are the number of compounds and the average observed activity of the training
set, and yi and ŷi are the observed and predicted activities of the i-th compound.
The procedure starts with the random selection of a predefined number of descriptors from all
descriptors. Activity of a compound yi excluded in the LOO cross-validation procedure is
predicted as the weighted average of activities of its nearest neighbors according to the
following formula:
(3)
where dij are distances between the i-th compound and its k nearest neighbors (j=1,…,k). The
optimal number of nearest neighbors that yields the highest q2 value is defined as part of the
LOO cross-validation process as well. After each run of the LOO procedure, a predefined
number of descriptors are randomly changed, and the new value of q2 is defined. If q2 (new)
> q2(old), the new set of descriptors is accepted. If q2 (new) ≤ q2(old), the new set of descriptors
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is accepted with probability p = exp(q2(new) - q2(old))/T, and rejected with probability (1-p),
where T is a simulated annealing “temperature” parameter. During the process, T is decreasing
until the predefined value, and when this value is achieved the optimization process is
terminated.
7. Y-randomization Test
The robustness of the models was examined by comparing them to those obtained when using
randomized binding affinities of the training set (this procedure is commonly referred to as Y-
randomization test). Briefly, we repeated the QSAR calculations with the randomized activities
of the training sets. We also compared the q2 values in the process of the iteration procedure
of the simulating annealing for actual and random activities of training sets to see if there is
any significant difference. This randomization was repeated five times for each splitting.
8. Model Validation and the Applicability Domain
QSAR models were validated using test sets. They were considered as acceptable, if (i) q2>0.5
and R2>0.6; (ii) [R2− R02]/R2<0.1 and 0.85<k<1.15 or [R2− R’02]/R2<0.1 and 0.85<k’ <1.15,
and (iii) |R02− R’02|<0.3,45 where R02 and R’02 are the coefficients of determination for
regressions through the origin between predicted and observed, and observed and predicted
binding energies, respectively, and k and k’ are the corresponding slopes. The whole QSAR
model validation procedure, as is illustrated in Figure 4, has been successfully used in our
laboratory for many datasets and is described in detail elsewhere73–75.
The binding affinity of the test set compounds was predicted only if these compounds were
within the applicability domain of the respective training set models. We define this
domain45 as a threshold distance in multidimensional descriptor space between a test set
compound and its k nearest neighbors in the training set. If the distance is beyond the threshold,
the prediction is considered unreliable. This threshold distance is calculated as D2cutoff =
<D2nn> + Z*VAR, where <D2nn> is the squared mean distance between each of the training
set compound and its k nearest neighbors, VAR is the variance of Dnn, and Z is a user-defined
parameter (the default value is 0.5).
Training set models that passed our validation criteria (i)–(iii) were used for the prediction of
the independent validation set of randomly selected compounds. For this exercise, we relied
on the consensus prediction, which consists of the averaging the binding affinities of each
compound predicted by all acceptable models37.
9. QSBR Model Validation Using Computational Docking Studies
The goal of this component of our studies was to query the QSPR models with respect to their
ability to differentiate between native bound conformations of the ligands and their decoys. In
addition, we have also questioned whether QSBR models could discriminate known binders
from those molecules that are known not to bind to the receptors, which is a rigorous test for
any docking method. We have randomly selected three complexes from the PDB. They were
human dihydrofolate reductase complexed with folate (1DHF)76, orotidine 5'-phosphate
decarboxylase complexed to 6-hydroxyuridine 5'-phosphate (BMP) (1DQX)77 and human P38
Map kinase in complex with BIRB796 (1KV2)78. 1DHF docking study was done with
FlexX79 implemented in SYBYL80 while 1DQX and 1KV2 poses were created using Autodock
3.081. In addition, aribinose was docked into the dihydrofolate reductase using FlexX79 and
the enzyme coordinates from 1DHF to create unnatural complex since it is known that aribinose
does not bind to the dihydrofolate reductase. We have employed the default docking parameters
unless otherwise specified. The ligands were considered flexible and 50 conformations were
docked and scored for each ligand.
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1. Atom Type Definition and ENTess Descriptor Generation
The nearest neighbor interacting atoms at the protein-ligand interface were defined by the
means of Delaunay tessellation as described in Methods. The examples of interfacial tetrahedra
are shown in Figure 5 for the complex between HIV protease and acetylpepstatin (PDB code
5HVP). Tetrahedra with edges (i.e., interatomic distances) exceeding 8Å were excluded. We
have applied this procedure to 517 protein-ligand complexes in the training set as described in
Methods and counted the number of occurrences of each of the 554 atom quadruplet types. If
the number of times a particular type occurred was higher than 50, we considered this
quadruplet type significant. Otherwise, this type was discarded leading to the reduction in the
number of independent variables for the subsequent analysis. 132 types of quadruplets were
found to occur with sufficiently high frequency (Figure 6). For each type of the tetrahedral
composition, the EN values of the four composing atoms were added up, and the resulting
sums for all of the tetrahedra belonging to this composition type were then added up again.
The result of these calculations represented the value of the descriptor (i.e., one of possible
132 descriptors) for the particular protein-ligand complex (see Figure 7 for the illustration).
All 132 descriptors were initially calculated for the dataset of 264 complexes with known
binding constants. Because the 264 dataset is only a subset of the 517 dataset, we found that
32 out of 132 descriptors had zero values so they were excluded from further consideration.
The final data matrix included 100 columns for the variables and 264 rows for the protein-
ligand complexes. We have applied variable selection k-nearest neighbor (kNN)74 to this
matrix to build models and establish correlations between binding affinities and the ENTess
descriptors as described below.
2. Building QSBR Models
In order to build validated QSBR models, we have divided the dataset of 264 receptor-ligand
complexes with known binding constants into training, test, and validation subsets multiple
times. Three different subsets of the entire dataset were generated initially by removing 24
randomly selected complexes that constituted the independent validation sets. In each case of
this initial division, the remaining subsets that included 240 compounds each were divided into
multiple training and test sets using the SE program as described in Methods. For every
division, 55 training set models were generated and then validated by predicting the binding
constants of the test sets. Due to stochastic nature of the SE algorithm, the number of divisions
was different for different chemically diverse samples selected from the original dataset. In the
end, as many as 1155 models for 21 divisions of the first sample of 240 complexes, 1045 models
for 19 divisions of the second sample, and 2310 models for 42 divisions of the third sample
were built and validated using variable selection kNN.
Application of the acceptability criteria discussed in the Methods section resulted in 354, 515
and 567 models for the three samples described above with q2 > 0.50 and R2 > 0.60. In order
to evaluate the statistically significant predictive power of the training set models, our test sets
typically included no less than 15% of the dataset. As could be expected, due to the high
diversity of the dataset, the q2 and R2 were found to depend on the division of the dataset. For
example, we were unable to obtain acceptable training set models for the 173/67 (training/test
set complexes) division but were able to generate highly predictive models for the 167/73
division, where the best model had R2 as high as 0.71 (cf. model 28 in Table 4).
These results could be explained as follows. As a result of the division, some complexes that
are potential outliers are included in the test set, which reduces the R2. On the contrary, if these
structures are included in the training set, the test set R2 could be much higher than the training
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set q2. With the criteria described above, an acceptable model was obtained with the test set
as large as 118 complexes, i.e., almost half of the entire dataset, with q2 = 0.53 and R2 = 0.63
(cf. model 30 Table 4).
3. Prediction of the Independent Validation Sets
It should be noted that the studies described above rely on the test sets to select the acceptable
training set models. So strictly speaking the above procedure can not be regarded as truly
external validation. On the contrary, successful prediction of the randomly selected
independent validation set of 24 compounds could be viewed as a realistic test of the models’
predictive power. We now discuss the results of this test under different prediction scenarios.
3.1. Prediction with the Best Individual Models—Table 4 presents 10 best models for
each experiment. Model 11 tops the list with R2 as high as 0.83 and q2 of 0.65. Figure 8 shows
the data fitting of experimental and predicted binding affinities for training and test sets. This
model was built with 45 descriptors resulting from variable selection procedures and three
nearest neighbors appeared to be optimal in the leave-one-out (LOO) cross-validation.
Figure 9 shows the trajectory of the SA-driven optimization of the q2 in developing the best
kNN models and Figure 10 shows the relationship between the number of the descriptors and
the q2 for the training set with real vs. randomized binding energies. The latter figure
demonstrates that the models built using true binding affinities for the training set afford
significantly higher q2 values as compared to the models generated with the randomized
binding energies.
To further validate the models, we made predictions for the independent validation set of 24
randomly selected complexes in three independent experiments (Table 3). For each individual
model, we have obtained fairly good correlation between the actual and predicted binding
affinity (Table 4); with the exception of Models 12 and 18 where R2 fell below 0.60; all other
models had R2 ranging from 0.60 to 0.80.
3.2. Predictions Using the Combined Training and Test Sets—All predictions
described in the previous section were made using training sets only. Since the dataset of 240
complexes was divided into the training and test sets rationally and the test set predictions were
used to select acceptable models it is logical to employ the (re)combined set for the prediction
of the independent validation set. Thus, all 240 compounds of the recombined dataset were
used for the binding affinity prediction of the independent validation set. We used the
descriptors selected and the optimal number of nearest neighbors obtained by the kNN training
set modeling. Perez et al.37 have reported previously that using a similar approach improves
the prediction accuracy. Following this approach, we made predictions for 24 complexes with
the 10 best models for each experiment (cf. Table 3) and the results were significantly better
than using only the training set compounds. In addition to R2, root mean squared deviation
(RMSD) between predicted and observed binding is also used to measure the accuracy of the
prediction. It is defined as in the literature15,48:
(4)
where  are predicted and observed logarithmic binding affinity respectively.
N is the number of the complexes. Gibbs free energy of binding ΔG is related to the binding
constant by:
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For instance, for the predictions made with the model 7 R2increased from 0.74 to 0.84 and
RMSD decreased from 0.97 (5.5kJ/mol) to 0.90 (5.1kJ/mol) (cf. Table 4 and Figure 11). Since
we only use training set models that have both internal and external high predictive power,
every compound in the combined set has nearest neighbors in the selected descriptor space
with approximately the same binding affinity. Obviously, combining the training and test sets
enriches the structural diversity of the dataset used for prediction such that there is a greater
chance for every external compound of finding close nearest neighbors. Furthermore, because
we are using the applicability domain threshold, the nearest neighbor relationships translate
into similar binding affinities leading to high values of the external R2.
3.3. Prediction with the Consensus Method—With the consensus approach, the binding
affinities for each of the 24 complexes in the independent validation set were predicted as the
average of the predicted binding affinities for each complex based on individual models. The
results, as shown in Table 4, demonstrate that the consensus prediction is relatively stable with
R2 of 0.85, 0.77 and 0.81 respectively. Figure 11 shows, that the consensus approach predicts
more data with higher correlation coefficient than any single model. Notably, as shown in Table
5, Model 12 has good q2 (0.66) and very high R2 (0.83) but the R2 for the prediction of the 24
external complexes is below 0.60. This indicates that even if both q2 and R2 are very high, it
does not guarantee that the external predictive power of an individual model is acceptable. On
the contrary, the consensus prediction usually yields acceptable predictive power. This result
is consistent with our previous observations44.
4. Analysis of Outliers
For each complex, if the difference between the predicted and experimental binding affinities
was greater than three logarithmic units (i.e., pKd), we regarded the complex as an outlier.
Based on this definition, we have observed several outliers in different experiments: 1STP82
in experiment 1, 1PHG83 in experiment 2, and 1STP and 7TLN84 in experiment 3. 1STP is a
very interesting complex which was observed as an outlier by several groups working in the
area of scoring function development17,21,79. The 1STP complex is unique and our predicted
affinity with different models underestimated the observed binding affinity by 4 to 7 pKd units.
The biotin–streptavidin complex has the highest known binding constant82 and it is the only
member of the SAV family (Table 1). Consequently, there are no analogs of this complex in
the training set. More importantly, Muegge and Martin21 pointed out that streptavidin functions
as tetramer; we only have monomeric complex crystal structures available whereas the
interaction with a second subunit increase the binding of biotin by eight orders of magnitude.
1PHG83 was predicted to have binding affinity ca. three pKd units lower than the experimental
value (for instance, Model 7 predicts pKd value for this complex as 5.52 while the observed
binding affinity is 8.66). It is cytochrome P450cam (Camphor 5-Monoxygenase) complexed
with metyrapone, and it contains the heme group as cofactor. Crystal structure indicates that
there is some interaction between the ligand and the heme group which is not taken into account
by our scoring function.
7TLN84 is a metalloproteinase covalently bound to its ligand INC (CH2CO(N-OH)Leu-
OCH3). In addition, there are four Ca2+ and one Zn2+ ions in the complexes. In this case, the
concurrent binding of these ions could affect the prediction of the binding affinity, as was
observed with 1LYB85. There are too few metal containing complexes in our training dataset
and our approach may not accurately describe interactions mediated by metal ions.
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In addition to the outliers, several complexes were found to be out of the applicability domain
in our experiments. This means they are too different from their respective training set
complexes in the 100 descriptor space. As described above, most of them have metal ions
which may induce large conformational changes upon ligand binding. For example, 1EBG86
and 4TMN87 are metal complexes with four magnesium ions and four calcium ions
respectively. Although we have descriptors for quadruplets that contain metal atoms, the
representation of the interaction interface is probably insufficient to characterize their metal-
mediated large conformational change upon ligand binding. In addition, ligands in these two
complexes contain PO3 and PO2 groups, respectively, which are not frequent in the entire
dataset. Another example is 1FKF,88 which is an immunophilin-immunosuppressant complex
in which the protein conformation changes insignificantly upon the ascomocin (FK506)
binding, but interestingly, the ligand FK506 undergoes a very large conformational change
when it binds. FK506 is an antibiotic with a very large molecular weight (804 Daltons). The
drug's association with the protein involves five hydrogen bonds; the protein hydrophobic
binding pocket is lined with conserved aromatic residues, and contains an unusual carbonyl
binding pocket88. We suppose that the training set model is incapable of describing these unique
interactions accurately. However, despite the small number of outliers, we suggest that the
ENTess descriptors as applied in kNN QSBR calculations in general led to highly predictive
models.
5. Robustness of the Models
As described in Methods, to evaluate the model robustness, we have performed the Y-
randomization test. As shown in Figure 9 and Figure 10, q2 values for models built with real
activities of the training set were always much higher than for those built with randomized
activities. In order to exclude a possibility of a chance correlations and overfitting, the Y-
randomization test was repeated five times for each splitting. The highest q2 for the random
datasets was 0.14 while the lowest q2 for the real datasets was 0.51. In general, if the
relationships between binding affinities and descriptors are not random, the models built with
randomized affinities of the training sets complexes must have no predictive ability. Indeed,
no predictive model built with randomized training set data was found.
6. Comparison with Other Scoring Functions
Our results were compared with those obtained earlier using both knowledge-based and
empirical scoring functions, as shown in Table 5. Since there are no standard training and test
sets used by different groups, the direct comparison is impossible. Compared to SMoG96,19
our training sets were a little bigger, but our prediction accuracy was much better, even for a
much bigger test set (118 complexes). As compared to other published results, we had test sets
of comparable size and much smaller training sets, but nevertheless our correlation coefficients
are much higher. Importantly, we have demonstrated that our method afforded high predictive
power for an external structurally diverse dataset. The alternative empirical scoring functions
demonstrated comparable results with relatively smaller training sets (except SCORE and
XSCORE48,49), but the test sets are also small, which highly influences the value of R2. In
summary, our models were rigorously validated using test sets, using the additional external
prediction set of 24 compounds to simulate the real application of the models, and by
performing Y-randomization test. The results demonstrate the high prediction power of our
models and the applicability of our novel geometrical chemical descriptors to binding affinity
prediction.
7. Validation Using Docking Studies
For each docking case, the resulted poses were grouped into different bins based on their RMSD
against the crystal structure (for 1DQX, 1DHF and 1KV2) or the lowest energy binding
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conformation (for unnatural aribinose-DHFR complex); the bin width was 0.5Å. The poses
with RMSD above 8Å were not considered. This process led to six non-empty bins for both
1DHF (actual pKd = 7.4)76 and 1KV2 (actual pKd = 10.0)78, and four non-empty bins for both
1DQX (actual pKd = 11.05)89 and the DHFR-aribinose unnatural complex. The poses with the
lowest estimated binding free energy were selected as representatives of each bin. Thus, we
have obtained six poses for 1DHF and 1KV2 and four poses for 1DQX and DHFR-aribinose
complexes.
The pKd resulting from consensus prediction using the best 30 ENTess models were used to
rank the aforementioned poses and the results are shown in Table 6. These results demonstrate
that, in all cases, ENTess predictions could clearly differentiate the native crystallographic
bound conformation from the other decoy poses. For instance, our results for 1DHF are
consistent with FlexX79 for the top ranked poses: ENTess top 1 and 2 were ranked 1 and 4 by
FlexX79 with 1.64 Å and 1.12Å of RMSD, respectively. Both of them actually belong to the
same binding conformation and orientation mode. All of the poses ranked low by FlexX were
also ranked low by ENTess. The low binding affinity (ca. 1 mM) predicted by ENTess
corresponded to poses with weak binding to the DHFR receptor. Similarly, ENTess estimations
were accurate for 1DQX and 1KV2: based on ENTess predictions all ligand conformations
with low RMSD are strong binders while the low ranked poses are decoys. Most interestingly,
aribinose was successfully docked into the DHFR binding pocket using FlexX79 while we
knew that the binding did not happen at all. Probably this is the problem of many of not all
existing docking programs. In contrast, ENTess suggests that all of the docked poses have very
low binding affinity (lower than 1 mM). This observation suggests that binding affinity
estimates using ENTess for poses generated with available docking programs can be used to
eliminate false positives.
8. Chemical Properties of Descriptors Implicated in Significant QSBR Models
QSBR models generated with variable selection kNN method can be characterized not only by
their statistical characteristics but also analyzed in terms of ENTess descriptors that best models
are built with. To this end, we have calculated the frequency of occurrence of those selected
descriptors found in 30 best models used for the prediction of external test sets. Table 7 shows
the most frequently occurring descriptor types. They demonstrate that frequent quadruplet
compositions of atom types include purely hydrophobic (such as four carbon atom tetrahedra),
hydrophilic (such as four oxygens or nitrogens or mixed polar atom type quadruplet
compositions) as well as tetrahedra with mixed polar and non-polar atom composition (e.g.,
including two carbon and two oxygen or nitrogen atoms). These results indicate that variable
selection kNN models tend to rely on chemically diverse descriptor types that capture major
intermolecular binding interactions such as hydrophobic effect and hydrogen bonds.
9. The Importance of Electronegativity for ENTess Descriptors
ENTess descriptors are very simple; since their values are approximately proportional to the
number of quadruplets with certain compositions it may appear that significant models could
be generated without taking into account the electronegativity values at all. In order to address
the importance of EN, we have repeated all calculations described above but using only the
numbers of occurrence of different tetrahedra as descriptors. Interestingly, the statistical
parameters for training and test set models were comparable with those using the ENTess
descriptors, with q2 ranging from 0.5 to 0.7 and R2 from 0.6 to 0.8 (data not shown). However,
the predictions of the external validation set with these models were much less accurate than
using the ENTess descriptors (the consensus prediction R2 values were always below 0.5).
Furthermore, the acceptable training set models, on average, constituted only about 15% of all
of the models built, which is far fewer than the 40% obtained when using the ENTess
descriptors.
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In a separate experiment, we used atomic weights as the property to generate descriptors in
place of EN. Similarly, the q2 and R2 for training/test set models, respectively, were comparable
with those generated with the ENTess descriptors. However, although the prediction of the
external validation set gave better results than using the occurrence numbers the models were
not as robust and stable as those built using EN values (the best R2 value for consensus
prediction was 0.63 for only one of the three external validation sets and much lower for the
other two validation sets, data not shown). We reason that using electronegativity to calculate
the ENTess descriptors affords better models since EN implicitly incorporates major atomic
properties that are important in intermolecular interactions such as polarity, energy, ability to
form hydrogen bond, etc. Including other atomic parameters certainly could further improve
our method as we continue its development. In the future studies, we plan to combine charges
with EN to derive more sophisticated and perhaps more robust descriptors. Nevertheless we
believe that the simplicity of the approach proposed in this paper and our demonstrated ability
to generate reliable QSBR models using ENTess descriptors makes these descriptors attractive
for a wide range of QSBR studies.
CONCLUSIONS
To the best of our knowledge, our studies represent the first attempt to use electronegativity
(EN) as a main parameter for the definition of atom types and descriptors for protein-ligand
binding affinity prediction based on QSBR approach. To develop structure-based scoring
function, we have combined the atomic EN with the geometrical description of the receptor-
ligand interface using Delaunay tessellation. Delaunay tessellation is a unique way to represent
the geometrical complementarity between receptors and ligands. Electronegativity has been
found to define important terms in the molecular energy functions. Based on these two
concepts, we have developed novel geometrical chemical descriptors. The descriptors have
been applied in QSBR studies of binding energies for a dataset of 264 receptor-ligand
complexes. QSBR models were built with the variable selection k-nearest neighbors (kNN)
algorithm based on simulated annealing.
Using the ENTess descriptors, we have built and validated the QSBR models for receptor-
ligand binding affinity prediction. Robust and accurate binding affinity predictions with R2 up
to 0.83 for the test sets and 0.85 for the independent validation set have been obtained (Table
4). Compared to the conventional atom type definitions16,20–22,43, our method is very simple
yet uses fundamental chemical and geometrical principles. Our current analysis relies only on
10 atom types in total and relatively small number of descriptors, which can be considered as
an additional advantage of this methodology. Comparison with other scoring functions has
demonstrated that our approach is accurate and efficient for the prediction of binding affinities
for diverse protein-ligand structures. Our QSBR models can be used to predict binding free
energy for protein-ligand complexes resulting from experimental studies or docking
calculations. We expect that as additional data become available90, the accuracy and the range
of applicability of our statistical scoring function will increase.
Acknowledgments
Special thanks are to Dr. M. Karthikeyan for providing the statistics for different atom types in chemical databases
and Dr. P. Itskowitz for providing the docking poses from AutoDock and valuable discussions concerning the use of
electronegativity in deriving the ENTess descriptors. We also thank Drs. J. Feng, B. Krishnamoorthy and S.Q. Zong
for their help with programming, and Mr. R. Shah for the discussions concerning the protein family classification.
The studies presented in this paper were supported by the NIH research grant GM066940.
Zhang et al. Page 13














1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The
Protein Data Bank. Nucleic Acids Res 2000;28:235–242. [PubMed: 10592235]
2. Gohlke H, Klebe G. Statistical potentials and scoring functions applied to protein-ligand binding. Curr.
Opin. Struct. Biol 2001;11:231–235. [PubMed: 11297933]
3. Halperin I, Ma B, Wolfson H, Nussinov R. Principles of docking: An overview of search algorithms
and a guide to scoring functions. Proteins 2002;47:409–443. [PubMed: 12001221]
4. Tame JR. Scoring functions: a view from the bench. J. Comput. Aided Mol. Des 1999;13:99–108.
[PubMed: 10091117]
5. Taylor RD, Jewsbury PJ, Essex JW. A review of protein-small molecule docking methods. J. Comput.
Aided Mol. Des 2002;16:151–166. [PubMed: 12363215]
6. Bohm HJ, Boehringer M, Bur D, Gmuender H, Huber W, Klaus W, Kostrewa D, Kuehne H, Luebbers
T, Meunier-Keller N, Mueller F. Novel inhibitors of DNA gyrase: 3D structure based biased needle
screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative
to random screening. J. Med. Chem 2000;43:2664–2674. [PubMed: 10893304]
7. Gruneberg S, Wendt B, Klebe G. Subnanomolar Inhibitors from Computer Screening: A Model Study
Using Human Carbonic Anhydrase II. Angew. Chem. Int. Ed Engl 2001;40:389–393. [PubMed:
11180334]
8. Grzybowski BA, Ishchenko AV, Shimada J, Shakhnovich EI. From knowledge-based potentials to
combinatorial lead design in silico. Acc. Chem. Res 2002;35:261–269. [PubMed: 12020163]
9. Ajay, Murcko MA. Computational methods to predict binding free energy in ligand-receptor
complexes. J. Med. Chem 1995;38:4953–4967. [PubMed: 8544170]
10. Martin YC. Diverse viewpoints on computational aspects of molecular diversity. J. Comb. Chem
2001;3:231–250. [PubMed: 11350246]
11. Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T,
Caldwell JW, Kollman PA. A second generation force-field for the simulation of proteins, nucleic
acids and organic molecules. J. Am. Chem. Soc 1995;117:5179–5187.
12. MacKerell AD Jr, Banavali N, Foloppe N. Development and current status of the CHARMM force
field for nucleic acids. Biopolymers 2000;56:257–265. [PubMed: 11754339]
13. Halgren TA. Merck molecular force field: 1. Basis, form, scope, parameterization, and performance
of MMFF94. J. Comput. Chem 1996;17:490–519.
14. Shoichet BK, Leach AR, Kuntz ID. Ligand solvation in molecular docking. Proteins 1999;34:4–16.
[PubMed: 10336382]
15. Bohm HJ. Prediction of binding constants of protein ligands: a fast method for the prioritization of
hits obtained from de novo design or 3D database search programs. J. Comput. Aided Mol. Des
1998;12:309–323. [PubMed: 9777490]
16. Head RD, Smythe ML, Oprea TI, Waller CL, Green SM, Marshall GR. VALIDATE: A new method
for the receptor-based prediction of binding affinities of novel ligands. J. Am. Chem. Soc
1996;118:3959–3969.
17. Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP. Empirical scoring functions: I. The
development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor
complexes. J. Comput. Aided Mol. Des 1997;11:425–445. [PubMed: 9385547]
18. Gohlke H, Hendlich M, Klebe G. Knowledge-based scoring function to predict protein-ligand
interactions. J. Mol. Biol 2000;295:337–356. [PubMed: 10623530]
19. DeWitte RS, Shakhnovich EI. SMoG: de novo design method based on simple, fast, and accurate
free energy estimates. 1. Methodology and supporting evidence. J. Am. Chem. Soc 1996;118:11733–
11744.
20. Ishchenko AV, Shakhnovich EI. SMall Molecule Growth 2001 (SMoG2001): an improved
knowledge-based scoring function for protein-ligand interactions. J. Med. Chem 2002;45:2770–
2780. [PubMed: 12061879]
21. Muegge I, Martin YC. A general and fast scoring function for protein-ligand interactions: a simplified
potential approach. J. Med. Chem 1999;42:791–804. [PubMed: 10072678]
Zhang et al. Page 14













22. Mitchell JBO, Laskowski RA, Alex A, Thornton JM. BLEEP-potential of mean force describing
protein-ligand interactions: I. Generating potential. J. Comput. Chem 1999;20:1165–1176.
23. Deng W, Breneman C, Embrechts MJ. Predicting protein-ligand binding affinities using novel
geometrical descriptors and machine-learning methods. J. Chem. Inf. Comput. Sci 2004;44:699–703.
[PubMed: 15032552]
24. Kollman PA. Free energy calculations: application to chemical and biochemical phenomenon. Chem.
Rev 1993;93:2395–2417.
25. Tanaka S, Scheraga HA. Statistical mechanical treatment of protein conformation. I. Conformational
properties of amino acids in proteins. Macromolecules 1976;9:142–159. [PubMed: 1249985]
26. Bader GD, Betel D, Hogue CW. BIND: the Biomolecular Interaction Network Database. Nucleic
Acids Res 2003;31:248–250. [PubMed: 12519993]
27. Zhang SX, Ying WS, Siahaan TJ, Jois SDS. Solution structure of a peptide derived from the beta
subunit of LFA-1. Peptides 2003;24:827–835. [PubMed: 12948834]
28. Roche O, Kiyama R, Brooks CL III. Ligand-protein database: linking protein-ligand complex
structures to binding data. J. Med. Chem 2001;44:3592–3598. [PubMed: 11606123]
29. Muegge I, Martin YC, Hajduk PJ, Fesik SW. Evaluation of PMF scoring in docking weak ligands to
the FK506 binding protein. J. Med. Chem 1999;42:2498–2503. [PubMed: 10411471]
30. Martin, YC. Quantiative Drug Design: A Critical Introduction. New York, Basel: Marcel Decker Inc;
1978. p. 1-425.
31. Cramer RD III, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect
of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc 1988;110:5959–5967.
32. Kulkarni SS, Gediya LK, Kulkarni VM. Three-dimensional quantitative structure activity
relationships (3-D-QSAR) of antihyperglycemic agents. Bioorg. Med. Chem 1999;7:1475–1485.
[PubMed: 10465422]
33. Kulkarni SS, Kulkarni VM. Three-dimensional quantitative structure-activity relationship of
interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study. J.
Med. Chem 1999;42:373–380. [PubMed: 9986707]
34. Tokarski JS, Hopfinger AJ. Prediction of ligand-receptor binding thermodynamics by free energy
force field (FEFF) 3D-QSAR analysis: application to a set of peptidometic renin inhibitors. J. Chem.
Inf. Comput. Sci 1997;37:792–811. [PubMed: 9254912]
35. Holloway MK, Wai JM, Halgren TA, Fitzgerald PM, Vacca JP, Dorsey BD, Levin RB, Thompson
WJ, Chen LJ, deSolms SJ. A priori prediction of activity for HIV-1 protease inhibitors employing
energy minimization in the active site. J. Med. Chem 1995;38:305–317. [PubMed: 7830273]
36. Ortiz AR, Pisabarro MT, Gago F, Wade RC. Prediction of drug binding affinities by comparative
binding energy analysis. J. Med. Chem 1995;38:2681–2691. [PubMed: 7629807]
37. Perez C, Pastor M, Ortiz AR, Gago F. Comparative binding energy analysis of HIV-1 protease
inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug
design. J. Med. Chem 1998;41:836–852. [PubMed: 9526559]
38. Carter CW Jr, LeFebvre BC, Cammer SA, Tropsha A, Edgell MH. Four-body potentials reveal
protein-specific correlations to stability changes caused by hydrophobic core mutations. J. Mol. Biol
2001;311:625–638. [PubMed: 11518520]
39. Sherman DB, Zhang SX, Pitner JB, Tropsha A. Evaluation of the relative stability of liganded versus
ligand-free protein conformations using simplicial neighborhood analysis of protein packing
(SNAPP) method. Proteins 2004;56:828–838. [PubMed: 15281134]
40. Zhang SX, Kaplan AH, Tropsha A. HIV-1 Protease Function and Structure Studies with Novel
Computational Geometrical Method. Proteins. Unpublished
41. Singh RK, Tropsha A, Vaisman II. Delaunay tessellation of proteins: four body nearest-neighbor
propensities of amino acid residues. J. Comput. Biol 1996;3:213–221. [PubMed: 8811483]
42. Tropsha A, Singh RK, Vaisman II, Zheng W. Statistical geometry analysis of proteins: implications
for inverted structure prediction. Pac. Symp. Biocomput 1996:614–623. [PubMed: 9390262]
43. Bush BL, Sheridan RP. PATTY: A Programmable Atom Typer and Language for Automatic
Classification of Atoms in Molecular Databases. J. Chem. Inf. Comput. Sci 1993;33:756–762.
Zhang et al. Page 15













44. Golbraikh A, Tropsha A. Beware of q2! J. Mol. Graph. Model 2002;20:269–276. [PubMed:
11858635]
45. Golbraikh A, Shen M, Xiao Z, Xiao YD, Lee KH, Tropsha A. Rational selection of training and test
sets for the development of validated QSAR models. J. Comput. Aided Mol. Des 2003;17:241–253.
[PubMed: 13677490]
46. Tropsha A, Gramatica P, Gomba VK. The improtance of being earnest: validation is the absolute
essential for the successful application and interpretaion of QSPR models. QSAR Comb. Sci
2003;22:69–77.
47. Tropsha, A. Recent Trends in Quantitative Structure-Activity Relationships. In: Abraham, D., editor.
Burger's Medicinal Chemistry and Drug Discovery. New York: John Wiley & Sons, Inc; 2003. p.
49-77.
48. Wang RX, Liu L, Lai LH, Tang YQ. SCORE: A new empirical method for estimating the binding
affinity of a protein-ligand complex. J. Mol. Model 1998;4:379–394.
49. Wang RX, Lai LH, Wang SM. Further development and validation of empirical scoring functions for
structure-based binding affinity prediction. J. Comput. Aided Mol. Des 2002;16:11–26. [PubMed:
12197663]
50. Wang RX, Lu YP, Wang SM. Comparative evaluation of 11 scoring functions for molecular docking.
J. Med. Chem 2003;46:2287–2303. [PubMed: 12773034]
51. Hendlich M, Bergner A, Gunther J, Klebe G. Relibase: design and development of a database for
comprehensive analysis of protein-ligand interactions. J. Mol. Biol 2003;326:607–620. [PubMed:
12559926]
52. 2005http://www.imb-jena.de/ImgLibPDB/pages/SWP/index.php
53. Pauling L. The Nature of the Chemical Bond. IV. The Energy of Single Bonds and the Relative
Electronegativity of Atoms. J. Am. Chem. Soc 1932;54:3570–3582.
54. Itskowitz P, Berkowitz ML. Chemical potential equalization principle: Direct approach from density
functional theory. J. Phys. Chem. A 1997;101:5687–5691.
55. Kellogg GE, Kier LB, Gaillard P, Hall LH. E-state fields: applications to 3D QSAR. J. Comput. Aided
Mol. Des 1996;10:513–520. [PubMed: 9007685]
56. Oliferenko AA, Krylenko PV, Palyulin VA, Zefirov NS. A new scheme for electronegativity
equalization as a source of electronic descriptors: application to chemical reactivity. SAR QSAR
Environ. Res 2002;13:297–305. [PubMed: 12071657]
57. 2005. http://dtp.nci.nih.gov/docs/3d_database/structural_information/smiles_strings.html
58. 1999. http://dtp.nci.nih.gov/docs/cancer/cancer_data.html
59. Watson DF. Computing the n-dimensional Delaunay tessellation with application to Voronoi
polytopes. The Computer J 1981;24:167–172.
60. Basak SC, Mills D. Prediction of mutagenicity utilizing a hierarchical QSAR approach. SAR QSAR
Environ. Res 2001;12:481–496. [PubMed: 11813801]
61. Benigni R, Giuliani A, Franke R, Gruska A. Quantitative structure-activity relationships of mutagenic
and carcinogenic aromatic amines. Chem. Rev 2000;100:3697–3714. [PubMed: 11749325]
62. Cronin MT, Dearden JC, Duffy JC, Edwards R, Manga N, Worth AP, Worgan AD. The importance
of hydrophobicity and electrophilicity descriptors in mechanistically-based QSARs for toxicological
endpoints. SAR QSAR Environ. Res 2002;13:167–176. [PubMed: 12074385]
63. Fan Y, Shi LM, Kohn KW, Pommier Y, Weinstein JN. Quantitative structure-antitumor activity
relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies. J.
Med. Chem 2001;44:3254–3263. [PubMed: 11563924]
64. Girones X, Gallegos A, Carbo-Dorca R. Modeling antimalarial activity: application of Kinetic Energy
Density Quantum Similarity Measures as descriptors in QSAR. J. Chem. Inf. Comput. Sci
2000;40:1400–1407. [PubMed: 11128098]
65. Moss GP, Dearden JC, Patel H, Cronin MT. Quantitative structure-permeability relationships
(QSPRs) for percutaneous absorption. Toxicol. In Vitro 2002;16:299–317. [PubMed: 12020604]
66. Randic M, Basak SC. Construction of high-quality structure-property-activity regressions: the boiling
points of sulfides. J. Chem. Inf. Comput. Sci 2000;40:899–905. [PubMed: 10955516]
Zhang et al. Page 16













67. Suzuki T, Ide K, Ishida M, Shapiro S. Classification of environmental estrogens by physicochemical
properties using principal component analysis and hierarchical cluster analysis. J. Chem. Inf. Comput.
Sci 2001;41:718–726. [PubMed: 11410051]
68. Trohalaki S, Gifford E, Pachter R. Improved QSARs for predictive toxicology of halogenated
hydrocarbons. Comput. Chem 2000;24:421–427. [PubMed: 10816012]
69. Wang X, Yin C, Wang L. Structure-activity relationships and response-surface analysis of
nitroaromatics toxicity to the yeast (Saccharomyces cerevisiae). Chemosphere 2002;46:1045–1051.
[PubMed: 11999768]
70. Kubinyi H, Hamprecht FA, Mietzner T. Three-dimensional quantitative similarity-activity
relationships (3D QSiAR) from SEAL similarity matrices. J. Med. Chem 1998;41:2553–2564.
[PubMed: 9651159]
71. Golbraikh A, Tropsha A. Predictive QSAR modeling based on diversity sampling of experimental
datasets for the training and test set selection. J. Comput. Aided Mol. Des 2002;16:357–369.
[PubMed: 12489684]
72. Shen M, LeTiran A, Xiao Y, Golbraikh A, Kohn H, Tropsha A. Quantitative structure-activity
relationship analysis of functionalized amino acid anticonvulsant agents using k nearest neighbor
and simulated annealing PLS methods. J. Med. Chem 2002;45:2811–2823. [PubMed: 12061883]
73. Hoffman B, Cho SJ, Zheng WF, Wyrick S, Nichols DE, Mailman RB, Tropsha A. Quantitative
structure-activity relationship modeling of dopamine D-1 antagonists using comparative molecular
field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods. J. Med.
Chem 1999;42:3217–3226. [PubMed: 10464009]
74. Zheng W, Tropsha A. Novel variable selection quantitative structure--property relationship approach
based on the k-nearest-neighbor principle. J. Chem. Inf. Comput. Sci 2000;40:185–194. [PubMed:
10661566]
75. Golbraikh A, Bonchev D, Tropsha A. Novel ZE-isomerism descriptors derived from molecular
topology and their application to QSAR analysis. J. Chem. Inf. Comput. Sci 2002;42:769–787.
[PubMed: 12132878]
76. Davies JF, Delcamp TJ, Prendergast NJ, Ashford VA, Freisheim JH, Kraut J. Crystal-Structures of
Recombinant Human Dihydrofolate-Reductase Complexed with Folate and 5-Deazafolate. Biochem
1990;29:9467–9479. [PubMed: 2248959]
77. Miller BG, Hassell AM, Wolfenden R, Milburn MV, Short SA. Anatomy of a proficient enzyme: The
structure of orotidine 5 '-monophosphate decarboxylase in the presence and absence of a potential
transition state analog. Proceedings of the National Academy of Sciences of the United States of
America 2000;97:2011–2016. [PubMed: 10681417]
78. Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG, Grob PM, Hickey ER, Moss
N, Pav S, Regan J. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nature
Structural Biology 2002;9:268–272.
79. Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental
construction algorithm. J. Mol. Biol 1996;261:470–489. [PubMed: 8780787]
80. SYBYL. Version 6.9. St. Louis, MO: Tripos, Inc.; 2002.
81. Goodsell DS, Olson AJ. Automated docking of substrates to proteins by simulated annealing. Proteins
1990;8:195–202. [PubMed: 2281083]
82. Weber PC, Ohlendorf DH, Wendoloski JJ, Salemme FR. Structural origins of high-affinity biotin
binding to streptavidin. Science 1989;243:85–88. [PubMed: 2911722]
83. Poulos TL, Howard AJ. Crystal structures of metyrapone- and phenylimidazole-inhibited complexes
of cytochrome P-450cam. Biochem 1987;26:8165–8174. [PubMed: 3442650]
84. Holmes MA, Tronrud DE, Matthews BW. Structural analysis of the inhibition of thermolysin by an
active-site-directed irreversible inhibitor. Biochem 1983;22:236–240. [PubMed: 6830761]
85. Baldwin ET, Bhat TN, Gulnik S, Hosur MV, Sowder RC, Cachau RE, Collins J, Silva AM, Erickson
JW. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal
targeting and drug design. Proc. Natl. Acad. Sci. U. S. A 1993;90:6796–6800. [PubMed: 8393577]
86. Wedekind JE, Poyner RR, Reed GH, Rayment I. Chelation of serine 39 to Mg2+ latches a gate at the
active site of enolase: structure of the bis(Mg2+) complex of yeast enolase and the intermediate
Zhang et al. Page 17













analog phosphonoacetohydroxamate at 2.1-A resolution. Biochem 1994;33:9333–9342. [PubMed:
8049235]
87. Holden HM, Tronrud DE, Monzingo AF, Weaver LH, Matthews BW. Slow-and fast-binding
inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended
phosphonamidate transition-state analogues. Biochem 1987;26:8542–8553. [PubMed: 3442675]
88. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J. Atomic structure of FKBP-FK506,
an immunophilin-immunosuppressant complex. Science 1991;252:839–842. [PubMed: 1709302]
89. Miller BG, Hassell AM, Wolfenden R, Milburn MV, Short SA. Anatomy of a proficient enzyme: The
structure of orotidine 5 '-monophosphate decarboxylase in the presence and absence of a potential
transition state analog. Proc. Natl. Acad. Sci. U. S. A 2000;97:2011–2016. [PubMed: 10681417]
90. Wang RX, Fang XL, Lu YP, Wang SM. The PDBbind database: Collection of binding affinities for
protein-ligand complexes with known three-dimensional structures. J. Med. Chem 2004;47:2977–
2980. [PubMed: 15163179]
Zhang et al. Page 18














Illustration of Voronoi/Delaunay tessellation in 2D space (Voronoi polyhedra are represented
by dashed line, and Delaunay simplices by solid line). For the collection of points with 3D
coordinates, such as atoms of the protein-ligand complex, Delaunay simplices are tetrahedra
whose vertices correspond to the atoms.
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RRRL: Formed by three receptor atoms and one ligand atom;
RRLL: Formed by two receptor atoms and two ligand atoms;
RLLL: Formed by one receptor atom and three ligand atoms.
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Flow chart of kNN-QSAR with Variable Selection.
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Statistical data modeling and model validation workflow using kNN variable selection
approach.
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Full atom-based protein-ligand interface tessellation for 5HVP. The magenta and red ribbons
are two chains of the protein. Acetylpepstatin ligand is in the spacefill display. Tetrahedra
formed by ligand and protein atoms are shown in yellow.
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Frequency analysis of 554 composition types for the 517 protein-ligand complex dataset. All
of the quadruplets on the left of the dashed line were found more than 50 times.
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Calculation of the ENTess descriptors. The same atom type from receptor and ligand is treated
differently. In the formulas, m is the m-th quadruplet composition type; n represents the number
of occurrences of this composition type in a given protein-ligand complex, and j is the vertex
index within the quadruplet.
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Predictive power of the best model (Model 11, cf. Table 4).
Grey open triangles: prediction for the 200 complexes of the training set (q2 = 0.65). Black
points: prediction for the 40 complexes of the test set (R2 = 0.83, RMSD = 1.06).
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Trajectories for q2 of the best model [Model 11] (solid black) and the model with the lowest
q2 (dashed grey). Trajectory of the model with the highest q2 (shadowed grey) built with
randomized binding energies of the training set.
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q2 vs. the number of variables selected for kNN QSAR models. The results are for both actual
(black) and random (grey) datasets. Every q2 is the average of 10 independent calculations.
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Prediction of binding affinities for the external validation test set (24 complexes) with different
approaches. (cf. Table 4). Asterisks: prediction with Model 7, Table 4. R2 = 0.74 and RMSD
= 0.97; Black open triangles: prediction with Model 7 using the whole dataset of 240 complexes
to select k nearest neighbors for compounds in the independent test set, R2 = 0.84 and RMSD
= 0.90; Grey points: consensus prediction by the top 10 best models using the whole dataset
of 240 complexes as the training set. R2 = 0.85 and RMSD = 0.98.
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O EN = 3.4
N EN = 3.0
C EN = 2.5
S EN = 2.4
X P and Halogens, EN = 2.0 ~ 2.4, 4.0
M Metal and all other rare atom types,
EN = 0.6 ~ 1.6
Receptor Atom Types
O EN = 3.4
N EN = 3.0
C EN = 2.5
S EN = 2.4
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Table 3
The Randomly Selected 24 Complexes in Three Experiments
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